drugset / Trial / NCT06056947
Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL Ovule
RandomizedParallel-groupOpen-labelTreatment
Summary
Efficacy and safety of two new formulations compared to Gynomax® XL ovule in the treatment of trichomonal vaginitis, bacterial vaginosis, candidal vulvovaginitis and mixed vaginal infections was evaluated in this randomized, three-arms, multicentral study.
Timeline
- Start
- 2020-07-20
- Primary completion
- 2021-05-06
- Completion
- 2021-08-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fenticonazole | Small molecule | 600 mg | Other |
| Subject | tinidazole | Small molecule | 300 mg | Other |
| Subject | tinidazole | Small molecule | 1000 mg | Other |
| Subject | tinidazole | Small molecule | 2000 mg | Other |
| Comparator | tioconazole | Small molecule | 200 mg | Other |
| Background | Lidocaine | Other / unclassified | 100 mg | Other |